Filing Details

Accession Number:
0001104659-25-019840
Form Type:
13G Filing
Publication Date:
2025-03-02 19:00:00
Filed By:
Aisling Capital V, LP
Company:
Calcimedica Inc. (NASDAQ:CALC)
Filing Date:
2025-03-03
SEC Url:
13G Filing
Ownership Summary

Please notice the below summary table is generated without human intervention and may contain errors. Please refer to the complete filing displayed below for exact figures.

Name Beneficially Owned Number of Shares Beneficially Owned Number of Aggregate Shares Percent of Class
Aisling Capital V, LP 0 781,671 3.9%
Aisling Capital Partners V, LP 0 781,671 3.9%
Aisling Capital Partners V LLC 0 781,671 3.9%
Dr. Andrew Schiff 0 781,671 3.9%
Steve Elms 0 781,671 3.9%
Filing





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Checkbox not checked   Rule 13d-1(b)
Checkbox checked   Rule 13d-1(c)
Checkbox not checked   Rule 13d-1(d)






SCHEDULE 13G




SCHEDULE 13G




SCHEDULE 13G




SCHEDULE 13G




SCHEDULE 13G




SCHEDULE 13G


 
Aisling Capital V, LP
 
Signature:/s/ Andrew Schiff
Name/Title:Andrew Schiff/Managing Member of Aisling Capital Partners V, LP, as General Partner of Aisling Capital Partners V LLC, its General Partner
Date:03/03/2025
 
Aisling Capital Partners V, LP
 
Signature:/s/ Andrew Schiff
Name/Title:Andrew Schiff/Managing Member of Aisling Capital Partners V LLC, its General Partner
Date:03/03/2025
 
Aisling Capital Partners V LLC
 
Signature:/s/ Andrew Schiff
Name/Title:Andrew Schiff/Managing Member
Date:03/03/2025
 
Dr. Andrew Schiff
 
Signature:/s/ Andrew Schiff
Name/Title:Andrew Schiff
Date:03/03/2025
 
Steve Elms
 
Signature:/s/ Steve Elms
Name/Title:Steve Elms
Date:03/03/2025